Related Experiment Video

Updated: Jul 7, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications

Alan N Elias1, Heather Hofflich

  • 1The University of California, Irvine Medical Center, Orange, CA 92868, USA. anelias@uci.edu

The American Journal of Medicine
|February 12, 2008
PubMed

Insights

Atypical antipsychotic medications increase diabetes risk in schizophrenia patients. This review explores how these drugs interact with hormones regulating appetite and metabolism to cause these effects.

Area of Science:

  • Endocrinology
  • Psychiatry
  • Pharmacology

Background:

  • Schizophrenia patients exhibit increased rates of carbohydrate intolerance and diabetes.
  • Atypical antipsychotic medications are associated with these metabolic abnormalities.
  • The underlying mechanisms linking these drugs to metabolic changes are not fully understood.

Purpose of the Study:

  • To review the potential interactions between atypical antipsychotic drugs and hormones involved in appetite and carbohydrate metabolism.
  • To elucidate the mechanisms behind the increased incidence of diabetes in schizophrenia patients on these medications.

Main Methods:

  • Literature review of studies on atypical antipsychotics, hormone regulation, and carbohydrate metabolism.
  • Analysis of hormonal pathways influencing appetite and glucose homeostasis.
  • Synthesis of current research on the metabolic side effects of atypical antipsychotics.

Main Results:

  • Atypical antipsychotics may disrupt hormonal signaling pathways.
  • Interactions with hormones like ghrelin, leptin, and insulin resistance are implicated.
  • These drug-hormone interactions can contribute to weight gain and impaired glucose control.

Conclusions:

  • Atypical antipsychotic medications can alter hormonal balances affecting metabolism.
  • Understanding these interactions is crucial for managing metabolic risks in schizophrenia.
  • Further research is needed to develop targeted interventions to mitigate these side effects.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...